A New Approach to the Dual Diagnosis Controversy
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
NIDA Monograph 172, Table of Contents
Treatment of Drug-Dependent Individuals With Comorbid Mental Disorders Editors: Lisa Simon Onken, Ph.D. Jack D. Blaine, M.D. Sander Genser, M.D., M.P.H. and Arthur MacNeill Horton, Jr., Ed.D. NIDA Research Monograph 172 1997 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse Division of Clinical Research 5600 Fishers Lane Rockville, MD 20857 i ACKNOWLEDGMENT This monograph is based on the papers from a technical review on "Comorbid Mental and Addictive Disorders: Treatment and HIV-Related Issues" held on September 27-28, 1994. The review meeting was sponsored by the National Institute on Drug Abuse. COPYRIGHT STATUS The National Institute on Drug Abuse has obtained permission from the copyright holders to reproduce certain previously published material as noted in the text. Further reproduction of this copyrighted material is permitted only as part of a reprinting of the entire publication or chapter. For any other use, the copyright holder's permission is required. All other material in this volume except quoted passages from copyrighted sources is in the public domain and may be used or reproduced without permission from the Institute or the authors. Citation of the source is appreciated. Opinions expressed in this volume are those of the authors and do not necessarily reflect the opinions or official policy of the National Institute on Drug Abuse or any other part of the U.S. Department of Health and Human Services. The U.S. Government does not endorse or favor any specific commercial product or company. Trade, proprietary, or company names appearing in this publication are used only because they are considered essential in the context of the studies reported herein. -
Principles of Community-Based Behavioral Health Services for Justice-Involved Individuals: a Research-Based Guide a Bridge to the Possible
Principles of Community-based Behavioral Health Services for Justice-involved Individuals: A Research-based Guide A bridge to the possible Acknowledgments This report was prepared for the Substance Abuse and Mental Health Services Administration (SAMHSA) under contract number HHSS283201200058I/HHSS28342003T with SAMHSA, U.S. Department of Health and Human Services (HHS). Nainan Thomas served as contracting officer representative. Disclaimer The views, opinions, and content of this publication are those of the author and do not necessarily reflect the views, opinions, or policies of SAMHSA or HHS. Nothing in this document constitutes a direct or indirect endorsement by SAMHSA or HHS of any non-federal entity’s products, services, or policies, and any reference to non-federal entities’ products, services, or policies should not be construed as such. Public Domain Notice All material appearing in this publication is in the public domain and may be reproduced or copied without permission from SAMHSA. Citation of the source is appreciated. However, this publication may not be reproduced or distributed for a fee without the specific, written authorization of the Office of Communications, SAMHSA, HHS. Electronic Access and Printed Copies This publication may be downloaded or ordered at http://store.samhsa.gov or by calling SAMHSA at 1-877-SAMHSA-7 (1-877-726-4727). Recommended Citation Substance Abuse and Mental Health Services Administration: Principles of Community-based Behavioral Health Services for Justice-involved Individuals: A Research-based Guide. HHS Publication No. SMA- 19-5097. Rockville, MD: Office of Policy, Planning, and Innovation. Substance Abuse and Mental Health Services Administration, 2019. Originating Office Office of Policy, Planning, and Innovation, Substance Abuse and Mental Health Services Administration, 5600 Fishers Lane, Rockville, MD 20857, HHS Publication No. -
Dual Diagnosis and Integrated Treatment of Mental Illnesses and Substance Use Disorders
Dual Diagnosis and Integrated Treatment of Mental Illnesses and Substance Use Disorders 1919 University Avenue West, Suite 400, St. Paul, MN 55104 Tel. 651-645-2948 or 888-NAMIHELPS www.namihelps.org What are dual diagnosis services? Dual diagnosis services are treatments for people who suffer from co-occurring disorders -- mental illness and substance abuse. Research has strongly indicated that to recover fully, a consumer with co-occurring disorder needs treatment for both problems -- focusing on one does not ensure the other will go away. Dual diagnosis services integrate assistance for each condition, helping people recover from both in one setting, at the same time. Dual diagnosis services include different types of assistance that go beyond standard therapy or medication: assertive outreach, job and housing assistance, family counseling, even money and relationship management. The personalized treatment is viewed as long-term and can be begun at whatever stage of recovery the consumer is in. Positivity, hope and optimism are at the foundation of integrated treatment. How often do people with severe mental illnesses also experience a co-occurring substance abuse problem? There is a lack of information on the numbers of people with co-occurring disorders, but research has shown the disorders are very common. According to reports published in the Journal of the American Medical Association (JAMA): • Roughly 50 percent of individuals with severe mental disorders are affected by substance abuse. • Thirty-seven percent of alcohol abusers and 53 percent of drug abusers also have at least one serious mental illness. • Of all people diagnosed as mentally ill, 29 percent abuse either alcohol or drugs. -
Dual Diagnosis: SHOW YOU CARE
or supportive housing. Some people find How to Get Help therapy to be a helpful part of maintaining No insurance? Call the NAMI Southern their sobriety. This can include individual Arizona office to help guide you to access DUAL therapy (e.g., cognitive behavioral therapy) mental health services. as well as self-help groups such as Alcoholics Anonymous, Narcotics If you have dual diagnosis: SHOW YOU CARE. DIAGNOSIS Anonymous or Smart Recovery. Seek medical care through a psychiatrist WEAR A SILVER RIBBON. Certain medications to help maintain and/or your primary care physician. sobriety have been safely tested in multiple studies. For alcoholism, available Find the right combination of treatment Help break down the barriers to FIND HELP. medications include disulfiram (Antabuse), that works for you which may include treatment and support. acamprosate (Campral) and naltrexone medication, therapy, support groups, Help reduce stigma —talk about it! FIND HOPE. (Revia). For opiate abuse, available etc. *Sometimes people must try medications include naltrexone (Revia, several different treatments or combinations of treatment before they Vivitrol), methadone and buprenorphine Mental illness affects 1 in 5 people. We (Subutex, Suboxone). Given how find the one that works for them. provide resources and support to all those complicated these choices may be, it is Take NAMI’s Peer-to-Peer course affected by mental illness. necessary for any individuals with dual and/or join the NAMI Connection diagnosis and their loved ones to discuss support group. NAMI SOUTHERN ARIZONA DEPENDS ON YOU. medication management strategies with their doctors. LEARN about your illness. The more you THERE ARE MANY WAYS TO HELP. -
The Therapeutic Community As an Adaptable Treatment Modality Across Different Settings
P1: KEG Psychiatric Quarterly [psaq] ph259-psaq-482367 June 3, 2004 10:30 Style file version June 4th, 2002 Psychiatric Quarterly, Vol. 75, No. 3, Fall 2004 (C 2004) THE THERAPEUTIC COMMUNITY AS AN ADAPTABLE TREATMENT MODALITY ACROSS DIFFERENT SETTINGS David Kennard Simple core statements of the therapeutic community as a treatment modal- ity are given, including a “living-learning situation” and “culture of enquiry.” Applications are described in work with children and adolescents, chronic and acute psychoses, offenders, and learning disabilities. In each area the evolu- tion of different therapeutic community models is outlined. In work with young people the work of Homer Lane and David Wills is highlighted. For long term psychosis services, the early influence of “moral treatment” is linked to the revitalisation of asylums and the creation of community based facilities; acute psychosis services have been have been run as therapeutic communities in both hospital wards and as alternatives to hospitalisation. Applications in prison are illustrated through an account of Grendon prison. The paper also outlines the geographical spread of therapeutic communities across many countries. KEY WORDS: therapeutic communities; children; psychosis; prison; learning disability. The author is Head of Psychological Services, The Retreat, York, England. Address correspondence to David Kennard, The Retreat, York, YO10 5BN, United Kingdom; e-mail: [email protected]. 295 0033-2720/04/0900-0295/0 C 2004 Human Sciences Press, Inc. P1: KEG Psychiatric Quarterly [psaq] ph259-psaq-482367 June 3, 2004 10:30 Style file version June 4th, 2002 296 PSYCHIATRIC QUARTERLY This is a paper about different adaptations of the basic therapeutic community idea. -
Crime & Delinquency
Crime & Delinquency http://cad.sagepub.com/ Five-Year Outcomes of Therapeutic Community Treatment of Drug-Involved Offenders after Release from Prison James A. Inciardi, Steven S. MartIn and Clifford A. ButzIn Crime & Delinquency 2004 50: 88 DOI: 10.1177/0011128703258874 The online version of this article can be found at: http://cad.sagepub.com/content/50/1/88 Published by: http://www.sagepublications.com Additional services and information for Crime & Delinquency can be found at: Email Alerts: http://cad.sagepub.com/cgi/alerts Subscriptions: http://cad.sagepub.com/subscriptions Reprints: http://www.sagepub.com/journalsReprints.nav Permissions: http://www.sagepub.com/journalsPermissions.nav Citations: http://cad.sagepub.com/content/50/1/88.refs.html >> Version of Record - Jan 1, 2004 What is This? Downloaded from cad.sagepub.com at UNIV OF DELAWARE LIB on August 2, 2014 CRIMEInciardi10.1177/0011128703258874 ARTICLE &et al.DELINQUENCY / FIVE-YEAR OUTCOMES/ JANUARY 2004 Five-Year Outcomes of Therapeutic Community Treatment of Drug-Involved Offenders After Release From Prison James A. Inciardi Steven S. Martin Clifford A. Butzin With growing numbers of drug-involved offenders, substance abuse treatment has become a critical part of corrections. A multistage therapeutic community implemented in the Delaware correctional system has as its centerpiece a residential treatment pro- gram during work release—the transition between prison and community. An evaluation of this program followed 690 individuals. At 5 years, those who participated in the pro- gram were significantly more likely to be drug and arrest free. Furthermore, treatment graduates with or without aftercare had significantly greater probabilities of remaining both arrest free and drug free than did a no treatment comparison group in regular work release. -
Judges' Primer on Mental Illness, Addictive Disorders, Co-Occurring
A Judges’ Primer on Mental Illness, Addictive Disorders, Co-occurring Disorders, and Integrated Treatment Understanding and Recognizing of an ingested substance. This includes intoxication and Mental Illness withdrawal symptoms which resolve after the substance is cleared from the brain. For example, acute and prolonged use Mental illnesses are neurobiological diseases of the brain, but of cocaine can cause paranoia, which would be diagnosed as the precise causes of mental disorders are complex and still a substance-induced delusional disorder rather than a serious not well understood. Like many physical illnesses, they are mental illness. The appropriate treatment for this condition is believed to be determined by an interplay of biological, psy- prolonged abstinence from cocaine. chological, and social factors. No single gene is likely to cause The substance use disorder diagnosis is further divided a particular mental illness; rather, the interaction of multiple into “substance abuse” and “substance dependence” disor- genes and environmental stressors increase the risk of mental ders. Whereas substance abuse is defined as a “pattern of disorders. substance use manifested by recurrent and significant adverse Anxiety, anger, and despair are normal reactions to the consequences related to the repeated use of substances,” stressful experience of being arrested. Even when exaggerated, substance dependence is a cluster of symptoms that indicates these symptoms by themselves may not constitute a diagnos- that an individual has lost the ability to control his or her use able mental disorder. Only through a clinician’s careful evalua- of a substance despite significant substance-related problems. tion of the nature and severity of symptoms, and the resultant Substance use disorders can involve any of the following impairments they cause, can a mental disorder be diagnosed. -
Real-World Challenges
Real-worldReal-world challengeschallenges Real-world challenges inin managingmanaging ‘dual‘dual diagnosis’diagnosis’ patientspatients Diligent assessment and judicious prescribing can help optimize outcomes Joseph M. Pierre, MD Health Sciences Clinical Professor he term “dual diagnosis” describes the clinically challeng- Department of Psychiatry and ing comorbidity of a substance use disorder (SUD) along Biobehavioral Sciences with another major mental illness. Based on data from the David Geffen School of Medicine at University of T California, Los Angeles Epidemiologic Catchment Area study, the lifetime prevalence of SUDs Los Angeles, California among patients with mental illness is approximately 30%, and is higher Disclosure among patients with certain mental disorders, such as schizophrenia The author reports no financial relationships with any (47%), bipolar disorder (61%), and antisocial personality disorder (84%).1 company whose products are mentioned in this article, or with manufacturers of competing products. These statistics highlight that addiction is often the rule rather than the exception among those with severe mental illness.1 Not surprisingly, the combined effects of having an SUD along with another mental illness are uniformly negative (Table 1,2-4 page 26). Based on outcomes research, the core tenets of evidence-based dual- diagnosis treatment include the importance of integrated (rather than parallel) and simultaneous (rather than sequential) care, which means an ideal treatment program includes a unified, multidisciplinary team whose coordinated efforts focus on treating both disorders concur- rently.2 Evidence-based psychotherapies for addiction, including moti- vational interviewing, cognitive-behavioral therapy, relapse prevention, contingency management, skills training, and/or case management, are a necessity,3,5 and must be balanced with rational and appropriate pharmacotherapy targeting both the SUD as well as the other disorder (Table 2,2,3,5-9 page 27). -
(G-CSF) in Patients with Substance Use Disorders and Comorbid
www.nature.com/scientificreports OPEN Plasma concentrations of granulocyte colony‑stimulating factor (G‑CSF) in patients with substance use disorders and comorbid major depressive disorder Sandra Torres Galván1,2,3,10, María Flores‑López1,2,4,10, Pablo Romero‑Sanchiz1,2,5, Nerea Requena‑Ocaña1,2, Oscar Porras‑Perales1,2,4,6, Raquel Nogueira‑Arjona1,2,5, Fermín Mayoral1,2, Pedro Araos1,2,4, Antonia Serrano1,2, Roberto Muga7,8, Francisco Javier Pavón1,2,6,9*, Nuria García‑Marchena3,7* & Fernando Rodríguez de Fonseca1,2,3* Granulocyte colony–stimulating factor (G‑CSF) has raised much interest because of its role in cocaine addiction in preclinical models. We explored the plasma concentrations of G‑CSF in patients diagnosed with substance use disorder (SUD) and highly comorbid psychiatric disorders. In particular, we investigated the association between G‑CSF concentrations and comorbid major depressive disorder (MDD) in patients with cocaine and alcohol use disorders (CUD and AUD, respectively). Additionally, patients with MDD but not SUD were included in the study. Three hundred and eleven participants were enrolled in this exploratory study: 136 control subjects, 125 patients with SUD (SUD group) from outpatient treatment programs for cocaine (N = 60, cocaine subgroup) and alcohol (N = 65, alcohol subgroup), and 50 patients with MDD but not SUD (MDD group) from primary‑care settings. Participants were assessed based on DSM‑IV‑TR criteria, and a blood sample was collected to examine the plasma concentrations of G‑CSF. G‑CSF concentrations were negatively correlated with age in the entire sample (r = − 0.233, p < 0.001) but not in the patients with MDD. -
The Therapeutic Community: a Unique Social Psychological Approach to the Treatment of Addictions and Related Disorders
PERSPECTIVE published: 06 August 2020 doi: 10.3389/fpsyt.2020.00786 The Therapeutic Community: A Unique Social Psychological Approach to the Treatment of Addictions and Related Disorders George De Leon 1 and Human F. Unterrainer 2,3,4* 1 Department of Psychiatry, NYU School of Medicine, New York City, NY, United States, 2 Center for Integrative Addiction Research (CIAR), Grüner Kreis Society, Vienna, Austria, 3 University Clinic for Psychiatry and Psychotherapeutic Medicine, Medical University Graz, Graz, Austria, 4 Institute for Religious Studies, University of Vienna, Vienna, Austria Edited by: Carlos Roncero, The evolution of the contemporary Therapeutic Community (TC) for addictions over the University of Salamanca, Spain past 50 years may be characterized as a movement from the marginal to the mainstream Reviewed by: of substance abuse treatment and human services. TCs currently serve a wide array of Deena Marie Walker, Oregon Health & Science University, clients and their diverse problems; through advances in research in treatment outcomes, United States the composition of staff has been reshaped, the duration of residential treatment has been Giuseppe Carrà, University of Milano-Bicocca, Italy reduced, the treatment goals have been reset and, to a considerable extent, the approach *Correspondence: of therapy itself has been modified. An overview of the TC as a distinct social- Human F. Unterrainer psychological method for treating addiction and related disorders is provided by this [email protected] paper. Included in this is a focus on the multifaceted psychological wounds that Specialty section: consistently show a strong association with addiction and thereby require initiating a This article was submitted to recovery process characterized by life-style and identity changes. -
Program Evaluation of the Pine Lodge Pre- Release Residential Therapeutic Community for Women Offenders in Washington State, Final Report
The author(s) shown below used Federal funds provided by the U.S. Department of Justice and prepared the following final report: Document Title: Program Evaluation of the Pine Lodge Pre- Release Residential Therapeutic Community for Women Offenders in Washington State, Final Report Author(s): Clayton Mosher Ph.D. ; Dretha Phillips Ph.D. Document No.: 196670 Date Received: October 03, 2002 Award Number: 99-RT-VX-K001 This report has not been published by the U.S. Department of Justice. To provide better customer service, NCJRS has made this Federally- funded grant final report available electronically in addition to traditional paper copies. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. FINAL REPORT ON THE PROGRAM EVALUATION OF THE PINE LODGE PRE-RELEASE RESIDENTIAL THERAPEUTIC COMMUNITY FOR WOMEN OFFENDERS IN WASHINGTON STATE* RESEARCH REPORT 0 1-33 PMO #I0328 November 2001 Prepared by Clayton Mosher, Ph.D., Co-Principal Investigator Department of Sociology mosher@vancouver. wsu.edu and Dretha Phillips, Ph.D., Co-Principal Investigator Social and Economic Sciences Research Center drethn@ww. edu Washington State University P.O. Box 644014--Wilson Hall 133 Pullman, WA 99 164-4014 509.335.15 11 FAX 509.335.01 16 .. Submitted to Laurie C. Bright, Program Manager . brightaojp. usdoj.gov National Institute of Justice 8 10 7'h Street, NW--Room 7327 - Washington, DC 2053 1 202.616.3624 FAX 202.616.0275 PROPERTY OF National Criminal Justice Reference Service (NCJRS) Box 6000 , Rockville, MD 20849-6000 *This project was supported by Grant No. -
Mental Health Effects of Recreational Drugs and Alcohol Understanding
Understanding the mental health effects of recreational drugs and alcohol understanding mental health effects of recreational drugs and alcohol 1 Understanding the mental health effects of recreational drugs and alcohol This booklet is for anyone who wants to know more about the mental health effects of recreational drugs and alcohol. It explains how drugs and alcohol affect mental health, and what might happen if you use recreational drugs and have a mental health problem. It also provides information on what support is available and guidance for friends and family. Contents What are recreational drugs and alcohol? 4 How can recreational drugs affect mental health? 5 What types of drugs are there? 8 What effect could different drugs have? 11 Can recreational drugs and medication affect each other? 32 What support is available? 36 What help is available if I have a dual diagnosis? 38 How can family and friends help? 42 Useful contacts 45 3 Understanding the mental health effects of recreational drugs and alcohol What are recreational drugs and alcohol? Drugs are substances people take: • to give themselves a pleasurable experience • to help them feel better if they are having a bad time • because their friends are using them • to see what it feels like. They include alcohol, tobacco (nicotine), substances such as cannabis, heroin, cocaine and ecstasy, and some prescribed medicines. All my experiences with recreational drug use started due to social influences, of wanting to 'fit in'. Recreational drugs may be: • legal – such as nicotine and alcohol • illegal – this means it is against the law to have them or supply them to other people; most recreational drugs are illegal • controlled – these are drugs used in medicine, such as benzodiazepines; it is legal to take controlled drugs if a doctor has given you a prescription for them but it is illegal to have them if not; it is also illegal to give or sell controlled drugs to anyone else.